Jean-Claude Schmit
Jean-Claude Schmit
Luxembourg Institute of Health
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
Transmission of drug-resistant HIV-1 is stabilizing in Europe
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification
D Struck, G Lawyer, AM Ternes, JC Schmit, DP Bercoff
Nucleic acids research 42 (18), e144-e144, 2014
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV …
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1145-1155, 2008
Updated European recommendations for the clinical use of HIV drug resistance testing
AM Vandamme, A Sönnerborg, M Ait-Khaled, J Albert, B Asjo, L Bacheler, ...
Antiviral therapy 9 (6), 829-848, 2004
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
AM Vandamme, RJ Camacho, F Ceccherini-Silberstein, A De Luca, ...
Aids Rev 13 (2), 77-108, 2011
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10, 1-13, 2013
European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results
C Suetens, I Morales, A Savey, M Palomar, M Hiesmayr, A Lepape, ...
Journal of Hospital Infection 65, 171-173, 2007
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
SMART Study Group*
Annals of internal medicine 149 (5), 289-299, 2008
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ...
Retrovirology 6 (1), 1-11, 2009
Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain
JC Schmit, J Cogniaux, P Hermans, C Van Vaeck, S Sprecher, ...
Journal of Infectious Diseases 174 (5), 962-968, 1996
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
DA van de Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006
Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test
AM Vandamme, JC Schmit, S Van Dooren, K Van Laethem, E Gobbers, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 13 (2), 127-139, 1996
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)
E De Clercq, AM Vandamme
Aids 10 (9), 995-999, 1996
Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda
A Fischer, C Lejczak, C Lambert, J Servais, N Makombe, J Rusine, ...
Journal of clinical microbiology 42 (1), 16-20, 2004
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
K Van Vaerenbergh, K Van Laethem, J Albert, CAB Boucher, B Clotet, ...
Antimicrobial agents and chemotherapy 44 (8), 2109-2117, 2000
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries
JC Schmit, K Van Laethem, L Ruiz, P Hermans, S Sprecher, ...
Aids 12 (15), 2007-2015, 1998
Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors
M Szpakowska, V Fievez, K Arumugan, N Van Nuland, JC Schmit, ...
Biochemical pharmacology 84 (10), 1366-1380, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20